US Broker Ratings

ICON plc (ICLR) Stock Analysis: Navigating the Healthcare Research Landscape with Promising Revenue Growth

ICON plc (NASDAQ: ICLR), an influential player in the healthcare sector, has carved a niche in the diagnostics and research industry. Based in Dublin, Ireland, ICON is a prominent clinical..

Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings and 29.74% Potential Upside Spark Investor Interest

Cencora, Inc. (NYSE: COR), a pivotal player in the healthcare sector, is emerging as a promising opportunity for investors seeking exposure to the medical distribution industry. With a formidable market..

Takeda Pharmaceutical Company L (TAK): Analyst Consensus and Potential 30.96% Upside for Investors

Takeda Pharmaceutical Company Limited (NYSE: TAK) presents a compelling opportunity for investors in the healthcare sector, particularly those interested in the specialty and generic drug manufacturing industry. As one of..

Ionis Pharmaceuticals (IONS) Stock Analysis: Exploring a 35.5% Upside Potential Amid Robust Revenue Growth

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading player in the biotechnology sector, is attracting significant investor interest with a compelling potential upside of 35.5%. With its innovative RNA-targeted therapies and..

Align Technology, Inc. (ALGN) Stock Analysis: Potential 24.64% Upside as Analysts Spotlight Growth Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the medical instruments and supplies sector, is capturing investor attention with its innovative solutions in orthodontics and intraoral scanning systems. Headquartered..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a Potential 14.32% Upside for Investors

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the healthcare sector, specifically within the medical devices industry, is garnering attention with its substantial market cap of $12.98 billion...

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Uncovering a 17.29% Potential Upside with Strong Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a key player in the biotechnology sector, has captured the attention of investors with its innovative approach to drug delivery using proprietary enzyme technology. With..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Uncharted Path in TCM Bioscience

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at the intersection of traditional Chinese medicine (TCM) and modern healthcare, carving a niche in the drug manufacturing industry with a focus on..

Elanco Animal Health (ELAN) Stock Analysis: A 26% Upside Potential in the Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, standing out as a prominent player in the animal health industry. With a market capitalization of $11.8..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Limited Upside Amid a Competitive Landscape

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is a key player in the medical devices industry. Headquartered in Hercules, California, this company boasts a market capitalization..

Revvity, Inc. (RVTY) Stock Analysis: A Compelling 15.53% Upside in the Healthcare Diagnostics Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specifically in diagnostics and research, presents an intriguing opportunity for investors with its potential upside of 15.53% according to recent..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 18% Upside and Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH) stands as a prominent player in the biotechnology industry, offering a diverse array of life science reagents, instruments, and services. With its headquarters in Minneapolis, Minnesota,..

Stevanato Group S.p.A. (STVN): Analyst Consensus Highlights 32.12% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) stands as a noteworthy contender in the healthcare sector, specializing in the design and manufacture of comprehensive solutions for the biopharmaceutical and healthcare industries. With..

Haleon plc (HLN) Stock Analysis: Analysts See a 28.73% Upside for This Healthcare Giant

Haleon plc (HLN), a United Kingdom-based leader in the healthcare sector, has been capturing investor attention with its robust portfolio of consumer healthcare products. With a market capitalization of $40.34..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 111.76% Potential Upside in the Biotech Sector

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its promising pipeline of therapies targeting serious and rare diseases. With a market capitalization of $20.42 billion, this healthcare..

West Pharmaceutical Services (WST) Stock Analysis: A 12% Upside Potential Amid Robust Revenue Growth

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $22.22 billion, this..

Option Care Health, Inc. (OPCH) Stock Analysis: 42% Potential Upside Beckons Investors

Option Care Health, Inc. (NASDAQ: OPCH) stands at the forefront of the healthcare sector, particularly within the medical care facilities industry, offering a compelling investment opportunity for those eyeing the..

Merck & Co., Inc. (MRK) Stock Analysis: Evaluating a 7.41% Upside Potential Amid Strong Buy Ratings

Merck & Co., Inc. (NYSE: MRK) stands as a cornerstone in the healthcare sector, with a commanding market capitalization of $298.33 billion. Renowned for its robust portfolio in pharmaceuticals and..

DexCom, Inc. (DXCM): Investor Outlook Reveals 13.92% Potential Upside in Continuous Glucose Monitoring Market

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, continues to command attention with its cutting-edge continuous glucose monitoring (CGM) systems. From its headquarters in..

Quest Diagnostics (DGX) Stock Analysis: Strong Upside Potential with Analyst Consensus

Investors seeking a solid opportunity in the healthcare sector might want to consider Quest Diagnostics Incorporated (NYSE: DGX), a leading player in the diagnostics and research industry. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds